Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report
Cardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan i...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
KARE Publishing
2019-01-01
|
Series: | Türk Kardiyoloji Derneği Arşivi |
Subjects: | |
Online Access: | https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383 |
id |
doaj-08b47b7cc1f44720946e95d9e91eff08 |
---|---|
record_format |
Article |
spelling |
doaj-08b47b7cc1f44720946e95d9e91eff082021-01-19T07:29:40ZengKARE PublishingTürk Kardiyoloji Derneği Arşivi1016-51692019-01-01471535610.5543/tkda.2018.46383TKDA-46383Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case reportUğur Önsel Türk0Emin Alioğlu1Department of Cardiology, Batı Anadolu Central Hospital, İzmir, TurkeyDepartment of Cardiology, Batı Anadolu Central Hospital, İzmir, TurkeyCardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan is recommended in the current guidelines as foundational therapy for patients with heart failure and reduced ejection fraction. However, the effects of sacubitril/valsartan treatment on these physiological parameters remain unclear. To the best of our knowledge, this is the first case objectively documenting improvements in ITI, PA, and HRV values with sacubitril/valsartan treatment.https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383cardiac implantable electronic devicesheart failureheart rate variabilityintrathoracic impedancephysical activity; remote monitoring; sacubitril/valsartan. |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Uğur Önsel Türk Emin Alioğlu |
spellingShingle |
Uğur Önsel Türk Emin Alioğlu Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report Türk Kardiyoloji Derneği Arşivi cardiac implantable electronic devices heart failure heart rate variability intrathoracic impedance physical activity; remote monitoring; sacubitril/valsartan. |
author_facet |
Uğur Önsel Türk Emin Alioğlu |
author_sort |
Uğur Önsel Türk |
title |
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report |
title_short |
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report |
title_full |
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report |
title_fullStr |
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report |
title_full_unstemmed |
Remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: A case report |
title_sort |
remote monitoring with cardiac implantable electronic device to follow up pharmacodynamic effects of sacubitril/valsartan treatment: a case report |
publisher |
KARE Publishing |
series |
Türk Kardiyoloji Derneği Arşivi |
issn |
1016-5169 |
publishDate |
2019-01-01 |
description |
Cardiac implantable electronic devices include remote monitoring tools intended to guide heart failure management. These tools allow for observation of some physiological functions, such as intrathoracic impedance (ITI), patient activity (PA), and heart rate variability (HRV). Sacubitril/valsartan is recommended in the current guidelines as foundational therapy for patients with heart failure and reduced ejection fraction. However, the effects of sacubitril/valsartan treatment on these physiological parameters remain unclear. To the best of our knowledge, this is the first case objectively documenting improvements in ITI, PA, and HRV values with sacubitril/valsartan treatment. |
topic |
cardiac implantable electronic devices heart failure heart rate variability intrathoracic impedance physical activity; remote monitoring; sacubitril/valsartan. |
url |
https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tkd&un=TKDA-46383 |
work_keys_str_mv |
AT uguronselturk remotemonitoringwithcardiacimplantableelectronicdevicetofollowuppharmacodynamiceffectsofsacubitrilvalsartantreatmentacasereport AT eminalioglu remotemonitoringwithcardiacimplantableelectronicdevicetofollowuppharmacodynamiceffectsofsacubitrilvalsartantreatmentacasereport |
_version_ |
1724332344561631232 |